Antibiotic resistant bacteria including carbapenemase-producing Enterobacteriaceae (CPE) are a serious global public health threat. Australia has not seen the same number of CPE cases compared to other parts of the world, this provides a valuable opportunity to develop strategies to identify, manage and control CPE within health settings.
The outbreak of Klebsiella pneumoniae carbapenemase in Victoria in 2014 highlighted a number of CPE related issues for Australian health settings. These issues include the absence of a national system for notification of CPE, variation in testing and reporting, and responses to CPE within jurisdictions, and there was no communication regarding CPE cases between Jurisdictions.
The Australian Commission on Safety and Quality in Health Care formed a Taskforce to respond to CPE. The CPE Taskforce produced Recommendations for the control of carbapenemase producing Enterobacteriaceae (CPE Guide). The aim of the CPE Guide in to alert key groups to the emerging threat of CPE in Australia, provide information and recommendations to assist health facilities in the planning, identification and management for CPE; and provide recommendations for laboratories.